Clindamycin and erythromycin inhibit protein synthesis by irreversibly binding to the ribosomal 50S subunit of P. acnes (Physician's Desk Reference, 2001). Whereas erythromycin is bactericidal ...
The US Food and Drug Administration (FDA) approved Iterum Therapeutics’ (Nasdaq: ITRM) Orlynvah (sulopenem etzadroxil and probenecid) oral sulopenem) for the treatment of uncomplicated urinary tract ...
ORLYNVAH™ is the first oral penem antibiotic to be approved in the U.S. and represents a new option for patients with limited or no alternative oral antibacterial treatments. The FDA's decision is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback